Citation, summary and a comment fro me below.
CITATION: Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance
Didier Wernli et al.
Lancet infectious Diseases 2020
Published:August 24, 2020
Improving evidence for action is crucial to tackle antimicrobial resistance. The number of interventions for antimicrobial resistance is increasing but current research has major limitations in terms of efforts, methods, scope, quality, and reporting. Moving the agenda forwards requires an improved understanding of the diversity of interventions, their feasibility and cost–benefit, the implementation factors that shape and underpin their effectiveness, and the ways in which individual interventions might interact synergistically or antagonistically to influence actions against antimicrobial resistance in different contexts. Within the efforts to strengthen the global governance of antimicrobial resistance, we advocate for the creation of an international One Health platform for online learning. The platform will synthesise the evidence for actions on antimicrobial resistance into a fully accessible database; generate new scientific insights into the design, implementation, evaluation, and reporting of the broad range of interventions relevant to addressing antimicrobial resistance; and ultimately contribute to the goal of building societal resilience to this central challenge of the 21st century.
e KEY MESSAGES
- Fundamental gaps in knowledge hinder effective action against antimicrobial resistance, but the limitations of research on interventions serve as even bigger obstacles...
- To foster learning across goals, regions, levels, and sectors, information about interventions for antimicrobial resistance can be consolidated into a fully accessible and continuously updated One Health online platform. Its main added value would be to provide searchable evidence about what works, for whom, and under what conditions.
- An open access learning platform on interventions for antimicrobial resistance should be useful to a broad range of stakeholders, including health-care professionals, public health practitioners, policy makers, industries, and consumer groups. It would not only provide the possibility of complementing published sources with new information, but also enable the exchange of ideas through online community tools.
- By working towards amplifying the generation of science-based and actionable knowledge, the platform would be a timely contribution to the goal of building societal resilience to the complex challenge of antimicrobial resistance. The integration of the One Health learning platform within the governance mechanism will help to maximise its usefulness and sustainability.
COMMENT (NPW): This paper seeks to address gaps in the knowledge base, but I would argue that lack of availability and use of existing knowledge is the elephant in the room that most people are ignoring. ‘Globally, most prescribers receive most of their prescribing information from the pharmaceutical industry and in many countries this is the only information they receive.’ World Medicines Report, WHO. The HIFA Prescribers and Users of Medicines project has been advocating for several years to ensure that "Every prescriber and user worldwide will have access to independent, reliable, understandable information on the full range of commonly prescribed medicines - and will know where to find it." http://www.hifa.org/projects/prescribers-and-users-medicines
Best wishes, Neil
Let's build a future where people are no longer dying for lack of healthcare information - Join HIFA: www.hifa.org
HIFA profile: Neil Pakenham-Walsh is coordinator of the HIFA global health campaign (Healthcare In
formation For All - www.hifa.org ), a global community with almost 20,000 members in 180 countries, interacting on six global forums in four languages (English, French, Spanish, Portuguese). Twitter: @hifa_org FB: facebook.com/HIFAdotORG email@example.com